Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Cheng Chi FungDirector, Chief Technology Officer |  CRDOCredo Technology Group Holding LtdOpen-market sale · 10b5-1 plan | SELL | $725K 4,500 sh | Oct 29, 2026 |
| 9 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $389K 2,400 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 9 | Twomey Christopher JDirector |  TNDMTANDEM DIABETES CARE INCOpen-market sale · 10b5-1 plan | SELL | $33K 1,700 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 9 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $384K 2,400 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 8 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $845K 2,331 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 8 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $45K 170 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 8 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $603K 1,681 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 8 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $41K 156 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 8 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $36K 134 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 8 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $44K 163 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 6 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $131K 800 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 6 | Mensinger MikeChief Product Officer |  BBNXBeta Bionics, Inc.Open-market sale · 10b5-1 plan | SELL | $58K 2,650 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 6 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $84K 500 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 6 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $94K 600 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 6 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $81K 500 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 6 | Bentley Sheldon RichardFounder |  CSAICLOUDASTRUCTURE, INC.Open-market sale · 10b5-1 plan | SELL | $3,405 1,500 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 4 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $313K 880 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 4 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $443K 1,239 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 4 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $332K 11.7K sh | Oct 29, 2026 traded Oct 28, 2026 |
| 4 | Boughton SoleilChief Legal Officer |  HIMSHims & Hers Health, Inc.Open-market sale · 10b5-1 plan | SELL | $96K 3,462 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 4 | Eisen Anthony MathewDirector |  XYZBlock, Inc.Open-market sale · 10b5-1 plan | SELL | $447K 6,000 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 4 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $336K 11.9K sh | Oct 29, 2026 traded Oct 29, 2026 |
| 4 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $460K 1,280 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 4 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $512K 1,440 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 3 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $31K 200 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 3 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $32K 200 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 3 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $48K 300 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 1 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $115K 320 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 1 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $244K 8,881 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 1 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $80K 3,000 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $5,780 200 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 0 | Sarowitz Steven IDirector, 10% Owner |  PCTYPaylocity Holding CorpOpen-market sale · 10b5-1 plan | SELL | $17K 100 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 0 | Robinhood Markets, Inc.10% Owner |  RVIRobinhood Ventures Fund IOpen-market sale · 10b5-1 plan | SELL | $4,725 189 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 47 | Lindecke DeanGeneral Manager Ergo Ops. |  DRDDRDGOLD LTDOpen-market sale | SELL | $119K 48.9K sh | Oct 28, 2026 traded Oct 27, 2026 |
| 47 | Kruger KevinHead of Technical Services | DRDDRDGOLD LTD Open-market sale | SELL | $180K 73.8K sh | Oct 28, 2026 traded Oct 27, 2026 |
| 47 | Moloto KgaboGeneral Manager FWGR Ops. | DRDDRDGOLD LTD Open-market sale | SELL | $54K 22.0K sh | Oct 28, 2026 traded Oct 27, 2026 |
| 47 | Schoeman JacobusChief Operating Officer | DRDDRDGOLD LTD Open-market sale | SELL | $231K 94.6K sh | Oct 28, 2026 traded Oct 27, 2026 |
| 47 | Gouws HenryHead of Prod., Dir. of Ergo | DRDDRDGOLD LTD Open-market sale | SELL | $218K 89.2K sh | Oct 28, 2026 traded Oct 27, 2026 |
| 46 | Burwig Susan EExec. VP, Operations |  MEDPMedpace Holdings, Inc.Open-market sale | SELL | $10.87M 16.1K sh | Oct 28, 2026 traded Oct 26, 2026 |
| 46 | Martins Izilda PChief Financial Officer |  SYMSymbotic Inc.Open-market sale | SELL | $281K 7,224 sh | Oct 28, 2026 traded Oct 28, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38MSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K